Register for Upcoming Webinar on DEC. 8 @ 11AM

China Green Pathways: Expedite your Market Entry in China

2026 China NMPA Bluebook is here:

Download Your Copy Today

[wpml_language_selector_widget]

white papers

Services

Get Updated

Receive Updates in Your Inbox

CMD Blog

NMPA Roundup June 2026

June 11, 2026

China’s Medical Device GMP Overhaul: Transition, Clarifications, and Key Compliance Upgrades

June 11, 2026

NMPA’s 2026 Post-Market Vigilance Framework: Essential Compliance Guide for Overseas Medical Device Manufacturers

May 25, 2026

Have Questions?

What is Conditional Approval?

Related Services

China NMPA Product Registration

Clinical Evaluation Report (CER)

Resources

NMPA (CFDA) Regulations

NMPA (CFDA) Newsletters

Recorded Webinars

White Papers

Brochures

Recent Events

RAPS Webcast: 2023 NMPA (CFDA) Key Updates and Look Ahead on 2024

Medical Device Made-in-China Policy: A Comprehensive Review and Implementation

Related Posts

NMPA Roundup June 2026

Here’s the latest China regulatory and clinical affairs news for

China’s Medical Device GMP Overhaul: Transition, Clarifications, and Key Compliance Upgrades

NMPA released the revised Good Manufacturing Practice (GMP) for Medical

NMPA’s 2026 Post-Market Vigilance Framework: Essential Compliance Guide for Overseas Medical Device Manufacturers

NMPA published seven guidelines on post-market surveillance for medical device

NMPA Review Report Released for B.Braun Avitum’s CRRT Hemofilter

The NMPA granted innovation approval to B.Braun Avitum’s CRRT hemofilter

11 Class III Devices and 66 IVDs to be Newly Exempted from Clinical Trial; Feedback until May 29

NMPA published the “Clinical Evaluation Exempt Draft Catalog for Medical

NMPA Clinical Updates: What Overseas Manufacturers Need to Know About the 5 New Class III Devices Guidelines

NMPA published 5 medical devices final guidelines on April 30,

Loading...